Morganella morganii infections in a general tertiary hospital

Infection

Volumn 34, Issue 6, 2006, Pages 315-321

  Falagas, M E ^a,b,c   Kavvadia, P K ^a   Mantadakis, E ^d   Kofteridis, D P ^d   Bliziotis, I A ^a   Saloustros, E ^d   Maraki, S ^d   Samonis, G ^d  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY DUNANT HOSPITAL   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; IMIPENEM; METRONIDAZOLE; NETILMICIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TICARCILLIN; TIMENTIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; APPENDICITIS; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; FEMALE; FEMALE GENITAL TRACT INFECTION; GANGRENE; GENERAL HOSPITAL; GRAM NEGATIVE INFECTION; GREECE; HUMAN; INFANT; MALE; MORGANELLA MORGANII; PRESCHOOL CHILD; PYELONEPHRITIS; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; SUPERINFECTION; TERTIARY HEALTH CARE; TONSILLITIS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GREECE; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORGANELLA MORGANII; RETROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS;

EID: 33845707469     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-6682-3     Document Type: Article

References (21)

1. O'Hara CM, Brenner FW, Miller JM: Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 2000; 13: 534-546.
2. Cox CE: Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria. Rev Infect Dis 1985; 7 Suppl 4: S767-S771.
3. Kim BN, Kim NJ, Kim MN, Kim YS, Woo JH, Ryu J: Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000). Scand J Infect Dis 2003; 35: 98-103.
4. Salen PN, Eppes S:Morganella morganii: a newly reported, rare cause of neonatal sepsis. Acad Emerg Med 1997; 4: 711-714.
5. Jorge MT, Ribeiro LA, da Silva ML, Kusano EJ, de Mendonca JS: Microbiological studies of abscesses complicating Bothrops snake-bite in humans: a prospective study.Toxicon 1994; 32: 743-748.
6. McDermott C, Mylotte JM: Morganella morganii: epidemiology of bacteremic disease. Infect Control 1984; 5: 131-137.
7. Tucci V, Isenberg HD: Hospital cluster epidemic with Morganella morganii. J Clin Microbiol 1981; 14: 563-566.
8. Samonis G, Anatoliotaki M, Apostolakou H, Souglakos J, Georgoulias V: Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease. Scand J Infect Dis 2001; 33: 553-555.
9. Del Pozo J, Garcia-Silva J, Almagro M, Martinez W, Nicolas R, Fonseca E: Ecthyma gangrenosum-like eruption associated with Morganella morganii infection. Br J Dermatol 1998; 139: 520-521.
10. Johnson JR, Feingold M: Case of chorioamnionitis in an immunocompetent woman caused by Morganella morganii. J Matern Fetal Med 1998; 7: 13-14.
11. Gautam V, Gupta V, Joshi RM, Sawhney G, Duhan S: Morganella morganii-associated arthritis in a diabetic patient. J Clin Microbiol 2003; 41: 3451.
12. Katz LM, Lewis RJ, Borenstein DG: Successful joint arthroplasty following Proteus morganii (Morganella morganii) septic arthritis: a four-year study. Arthritis Rheum 1987; 30: 583-585.
13. Christensen SR, Hansen AB, La Cour M, Fledelius HC: Bilateral endogenous bacterial endophthalmitis: a report of four cases. Acta Ophthalmol Scand 2004; 82: 306-310.
14. Tsanaktsidis G, Agarwal SA, Maloof AJ, Chandra J, Mitchell P: Postoperative Morganella morganii endophthalmitis associated with subclinical urinary tract infection. J Cataract Refract Surg 2003; 29: 1011-1013.
15. Damron DJ, Warren JW, Chippendale GR, Tenney JH: Do clinical microbiology laboratories report complete bacteriology in urine from patients with long-term urinary catheters? J Clin Microbiol 1986; 24: 400-404.
16. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. In: 9th Informational Suppl. NCCLS, Wayne, PA, 1999.
17. Gaynes RP, Horan TC: Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections. In: Mayhall CG (ed): Hospital epidemiology and infection control. Williams & Wilkins, Baltimore, 1996, pp 1-14.
18. Williams EW, Hawkey PM, Penner JL, Senior BW, Barton LJ: Serious nosocomial infection caused by Morganella morganii and Proteus mirabilis in a cardiac surgery unit. J Clin Microbiol 1983; 18: 5-9.
19. Stock I, Wiedemann B: Identification and natural antibiotic susceptibility of Morganella morganii. Diagn Microbiol Infect Dis 1998; 30: 153-165.
20. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP: Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004; 3: 14.
21. Navon-Venezia S, Hammer-Munz O, Schwartz D, Turner D, Kuzmenko B, Carmeli Y: Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. J Clin Microbiol 2003; 41: 155-158.